Q3 2024 EPS Estimates for Acadia Healthcare Company, Inc. Decreased by Zacks Research (NASDAQ:ACHC)

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Analysts at Zacks Research reduced their Q3 2024 earnings per share (EPS) estimates for shares of Acadia Healthcare in a research report issued to clients and investors on Monday, October 14th. Zacks Research analyst Z. Masood now anticipates that the company will earn $0.88 per share for the quarter, down from their prior forecast of $0.90. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.51 per share. Zacks Research also issued estimates for Acadia Healthcare's Q4 2024 earnings at $0.83 EPS, FY2024 earnings at $3.46 EPS, Q1 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.98 EPS, Q4 2025 earnings at $1.05 EPS, FY2025 earnings at $3.86 EPS and Q1 2026 earnings at $0.93 EPS.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, beating analysts' consensus estimates of $0.87 by $0.04. The firm had revenue of $796.00 million during the quarter, compared to analysts' expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The company's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.92 earnings per share.

Several other research analysts also recently commented on the company. KeyCorp initiated coverage on Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating for the company. Cantor Fitzgerald reissued a "neutral" rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Royal Bank of Canada reaffirmed an "outperform" rating and set a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a "hold" rating in a report on Friday, August 2nd. Finally, Barclays reduced their price objective on Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating for the company in a report on Monday, September 30th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, Acadia Healthcare has an average rating of "Hold" and a consensus target price of $86.67.

Acadia Healthcare Stock Performance

Acadia Healthcare stock traded up $0.43 during midday trading on Wednesday, reaching $57.39. 875,439 shares of the company's stock were exchanged, compared to its average volume of 904,805. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The stock's 50-day simple moving average is $71.37 and its 200 day simple moving average is $69.79. The firm has a market cap of $5.32 billion, a price-to-earnings ratio of -409.93, a P/E/G ratio of 1.57 and a beta of 1.29. Acadia Healthcare has a 52 week low of $53.22 and a 52 week high of $87.77.

Institutional Trading of Acadia Healthcare

Institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. lifted its position in Acadia Healthcare by 5.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 454,793 shares of the company's stock worth $35,365,000 after purchasing an additional 22,290 shares during the period. Vanguard Group Inc. boosted its position in shares of Acadia Healthcare by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company's stock worth $689,065,000 after acquiring an additional 30,296 shares in the last quarter. Mather Group LLC. bought a new position in Acadia Healthcare in the first quarter valued at approximately $48,000. Vaughan Nelson Investment Management L.P. raised its position in Acadia Healthcare by 40.6% during the first quarter. Vaughan Nelson Investment Management L.P. now owns 436,880 shares of the company's stock valued at $34,610,000 after purchasing an additional 126,220 shares in the last quarter. Finally, State of Michigan Retirement System lifted its stake in Acadia Healthcare by 2.3% during the first quarter. State of Michigan Retirement System now owns 22,630 shares of the company's stock worth $1,793,000 after purchasing an additional 500 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.